{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:31:59Z","timestamp":1789115519699,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010814","name":"Anhui Provincial Department of Education","doi-asserted-by":"publisher","award":["2024AH050809"],"award-info":[{"award-number":["2024AH050809"]}],"id":[{"id":"10.13039\/501100010814","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tranon.2026.102808","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:26:28Z","timestamp":1780565188000},"page":"102808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multi-omics analysis identifies CKLF as a promoter for HCC progression by regulating the AKT, ERK pathways, and infiltrating immune cells"],"prefix":"10.1016","volume":"70","author":[{"given":"Lei","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizhou","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2026.102808_bib0001","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41746-025-02281-y","article-title":"Artificial intelligence-based personalized treatment strategies for unresectable hepatocellular carcinoma: integrating HSP90\u03b1 for prognosis and survival prediction","volume":"9","author":"Su","year":"2025","journal-title":"NPJ Digit. Med."},{"issue":"4","key":"10.1016\/j.tranon.2026.102808_bib0002","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J. Hepatol."},{"issue":"27","key":"10.1016\/j.tranon.2026.102808_bib0003","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302640","article-title":"Micro-engineered organoid-on-a-chip based on mesenchymal stromal cells to predict immunotherapy responses of HCC patients","volume":"10","author":"Zou","year":"2023","journal-title":"Adv. Sci."},{"issue":"13","key":"10.1016\/j.tranon.2026.102808_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202307242","article-title":"YTHDF2 Is a therapeutic target for HCC by suppressing immune evasion and angiogenesis through ETV5\/PD-L1\/VEGFA axis","volume":"11","author":"Wen","year":"2024","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.tranon.2026.102808_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/biof.2130","article-title":"CXC chemokine receptor 4 - mediated immune modulation and tumor microenvironment heterogeneity in gastric cancer: utilizing multi-omics approaches to identify potential therapeutic targets","volume":"51","author":"Tang","year":"2025","journal-title":"BioFactors"},{"issue":"3","key":"10.1016\/j.tranon.2026.102808_bib0006","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/15548627.2023.2276639","article-title":"CKLF induces microglial activation via triggering defective mitophagy and mitochondrial dysfunction","volume":"20","author":"Wang","year":"2024","journal-title":"Autophagy"},{"issue":"11","key":"10.1016\/j.tranon.2026.102808_bib0007","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh9547","article-title":"CKLF instigates a \"cold\" microenvironment to promote MYCN-mediated tumor aggressiveness","volume":"10","author":"Qin","year":"2024","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.tranon.2026.102808_bib0008","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3390\/ijms24032652","article-title":"The role of PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma metabolism","volume":"24","author":"Tian","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.tranon.2026.102808_bib0009","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41419-021-03596-w","article-title":"The fatty acid receptor CD36 promotes HCC progression through activating src\/PI3K\/AKT axis-dependent aerobic glycolysis","volume":"12","author":"Luo","year":"2021","journal-title":"Cell Death. Dis."},{"issue":"1","key":"10.1016\/j.tranon.2026.102808_bib0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12967-022-03416-5","article-title":"VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K\/AKT\/mTOR pathway","volume":"20","author":"Pu","year":"2022","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.tranon.2026.102808_bib0011","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.70018","article-title":"Exploring the therapeutic potential of MIR-140-3p in osteoarthritis: targeting CILP and ferroptosis for novel treatment strategies","volume":"58","author":"Ma","year":"2025","journal-title":"Cell Proliferation"},{"issue":"13","key":"10.1016\/j.tranon.2026.102808_bib0012","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70685","article-title":"The key role of COA6 in pancreatic ductal adenocarcinoma: metabolic reprogramming and regulation of the immune microenvironment","volume":"29","author":"Jiang","year":"2025","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.tranon.2026.102808_bib0013","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12672-025-01760-8","article-title":"Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer","volume":"16","author":"Chen","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.tranon.2026.102808_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153782","article-title":"Natural products: potential targets of TME related long non-coding RNAs in lung cancer","volume":"93","author":"Malla","year":"2021","journal-title":"Phytomedicine"},{"issue":"13","key":"10.1016\/j.tranon.2026.102808_bib0015","first-page":"3287","article-title":"The sex-related interplay between TME and cancer: on the critical role of estrogen","volume":"13","author":"Matarrese","year":"2021","journal-title":"MicroRNAs Autophagy Cancers"},{"issue":"1","key":"10.1016\/j.tranon.2026.102808_bib0016","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-022-01304-5","article-title":"Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application","volume":"15","author":"Zhang","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102808_bib0017","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12967-024-05301-9","article-title":"The tumour microenvironment, treatment resistance and recurrence in glioblastoma","volume":"22","author":"White","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.tranon.2026.102808_bib0018","article-title":"Advances in targeting tumor microenvironment for immunotherapy","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.tranon.2026.102808_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0321037","article-title":"Comprehensive analysis of CMTM family and immune infiltration in esophageal carcinoma","volume":"20","author":"Xue","year":"2025","journal-title":"PLoS. One"},{"key":"10.1016\/j.tranon.2026.102808_bib0020","article-title":"Oncogenic CMTM6 drives M2a macrophages formation and fuels cervical cancer progression","volume":"16","author":"Yin","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102808_bib0021","article-title":"CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.tranon.2026.102808_bib0022","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011776","article-title":"Inhibiting CMTM4 reverses the immunosuppressive function of myeloid-derived suppressor cells and augments immunotherapy response in cervical cancer","volume":"13","author":"Ding","year":"2025","journal-title":"J. ImmunOther Cancer"},{"issue":"30","key":"10.1016\/j.tranon.2026.102808_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202504436","article-title":"Exosomal CMTM4 induces immunosuppressive macrophages to promote ovarian cancer progression and attenuate anti-PD-1 immunotherapy","volume":"12","author":"Yin","year":"2025","journal-title":"Adv. Sci."},{"issue":"9","key":"10.1016\/j.tranon.2026.102808_bib0024","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3724\/abbs.2024024","article-title":"The mechanism by which piR-000699 targets SLC39A14 regulates ferroptosis in aging myocardial ischemia\/reperfusion injury","volume":"56","author":"Chi","year":"2024","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"1","key":"10.1016\/j.tranon.2026.102808_bib0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2478\/jtim-2023-0006","article-title":"Efficacy and safety of avatrombopag in aplastic anemia patients with liver disease","volume":"11","author":"Wang","year":"2023","journal-title":"J. Transl. Int. Med."},{"issue":"2","key":"10.1016\/j.tranon.2026.102808_bib0026","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ajur.2024.09.006","article-title":"Deciphering riddles in molecular subtyping of bladder cancer","volume":"12","author":"Li","year":"2025","journal-title":"Asian J. Urol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:40:52Z","timestamp":1789112452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326001452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":26,"alternative-id":["S1936523326001452"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102808","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-omics analysis identifies CKLF as a promoter for HCC progression by regulating the AKT, ERK pathways, and infiltrating immune cells","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102808","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102808"}}